Lower mortality in patients with the DD genotype of the angiotensin-converting enzyme gene after acute myocardial infarction

Acta Cardiol. 2001 Dec;56(6):351-5. doi: 10.2143/AC.56.6.2005698.

Abstract

Objective: The angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism has been associated with different serum ACE concentrations and cardiac ACE activity. We assessed whether the ACE gene I/D polymorphism influenced cardiac mortality in Japanese patients with acute myocardial infarction.

Methods and results: The ACE gene I/D polymorphism was determined in 441 consecutive patients with a first myocardial infarction. There were 69 patients (16%) with the DD genotype, 194 patients (44%) with the ID genotype, and 178 patients (40%) with the II genotype. During a mean follow-up of 9.4 months, there were 49 cardiac deaths (DD, n = 4; ID, n = 26; II, n = 19). The DD genotype was significantly associated with a lower mortality than the other genotypes (p = 0.0363) by Cox regression analysis adjusted for age, sex, site of myocardial infarction, Killip functional class, reperfusion therapy during acute phase, ACE inhibitor use, and beta-blocker use.

Conclusions: In a selected cohort of Japanese patients, the DD genotype was associated with a significantly lower cardiac mortality after a first myocardial infarction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / genetics*
  • Myocardial Infarction / mortality*
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Genetic
  • Regression Analysis
  • Survival Analysis

Substances

  • Peptidyl-Dipeptidase A